Market Cap ₹106 Cr.
Stock P/E 15.2
P/B 2.1
Current Price ₹42.6
Book Value ₹ 20.3
Face Value 10
52W High ₹47.2
Dividend Yield 0%
52W Low ₹ 30
Dollex Agrotech Limited is an indigenous sugar manufacturing and trading company with a rich history and a promising future. Incorporated on June 10, 2013, under the Companies Act, 1956, Dollex Agrotech has evolved to include captive power co-generation capabilities. Company’s journey began with the vision of its promoters, who possess extensive experience in sugar manufacturing. In 2017, under the leadership of Mr. Mehmood Khan, the Director, Dollex Agrotech decided to establish a sugar manufacturing plant, which commenced operations in 2018 in Datia, Madhya Pradesh. The plant, located at Village Erai, Tehsil Badoni Khurd, boasts a crushing capacity of 2500 TCD. The company has also received in-principle approval from the Department of Food & Public Distribution, Government of India, for establishing distilleries of 200 KLPD capacity. Dollex Agrotech produces and sells by-products such as molasses, press mud, and bagasse, with the latter being used to generate up to 3 MW of captive power
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|
Net Sales | 25 | 77 | 79 | 110 | 135 | |
Other Income | 1 | 0 | 0 | 0 | 0 | |
Total Income | 26 | 78 | 80 | 111 | 136 | |
Total Expenditure | 21 | 71 | 71 | 98 | 122 | |
Operating Profit | 5 | 7 | 9 | 13 | 14 | |
Interest | 2 | 2 | 2 | 2 | 3 | |
Depreciation | 2 | 2 | 2 | 3 | 3 | |
Exceptional Income / Expenses | -0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 3 | 4 | 8 | 8 | |
Provision for Tax | 1 | 1 | 1 | 2 | 1 | |
Profit After Tax | 1 | 2 | 3 | 6 | 7 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 2 | 3 | 6 | 7 | |
Adjusted Earnings Per Share | 0.6 | 0.8 | 1.6 | 2.4 | 2.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 23% | 21% | 0% | 0% |
Operating Profit CAGR | 8% | 26% | 0% | 0% |
PAT CAGR | 17% | 52% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 18% | NA% | NA% | NA% |
ROE Average | 13% | 14% | 11% | 11% |
ROCE Average | 9% | 10% | 9% | 9% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|
Shareholder's Funds | 12 | 23 | 26 | 50 | 58 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 |
Borrowings | 51 | 47 | 40 | 33 | 93 |
Other Non-Current Liabilities | 1 | 2 | 3 | 3 | 3 |
Total Current Liabilities | 25 | 32 | 44 | 83 | 118 |
Total Liabilities | 89 | 105 | 114 | 168 | 271 |
Fixed Assets | 46 | 44 | 39 | 35 | 32 |
Other Non-Current Assets | 7 | 5 | 4 | 8 | 50 |
Total Current Assets | 36 | 56 | 70 | 125 | 189 |
Total Assets | 89 | 105 | 114 | 168 | 271 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | -1 | 3 | 6 | 1 |
Cash Flow from Operating Activities | -9 | 0 | 10 | -20 | -43 |
Cash Flow from Investing Activities | -8 | -2 | 3 | 3 | -7 |
Cash Flow from Financing Activities | 15 | 6 | -10 | 13 | 59 |
Net Cash Inflow / Outflow | -2 | 4 | 3 | -5 | 9 |
Closing Cash & Cash Equivalent | -1 | 3 | 6 | 1 | 10 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.58 | 0.84 | 1.63 | 2.45 | 2.81 |
CEPS(Rs) | 2.45 | 2.04 | 2.77 | 3.45 | 3.94 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 11.55 | 11.61 | 13.25 | 20.02 | 23.17 |
Core EBITDA Margin(%) | 17.57 | 8.65 | 10.83 | 11.61 | 10.32 |
EBIT Margin(%) | 12.45 | 6.22 | 8.48 | 9.43 | 8.35 |
Pre Tax Margin(%) | 5.13 | 3.39 | 5.35 | 7.21 | 5.99 |
PAT Margin (%) | 2.28 | 2.17 | 4.12 | 5.53 | 5.18 |
Cash Profit Margin (%) | 9.69 | 5.28 | 6.98 | 7.81 | 7.27 |
ROA(%) | 0.65 | 1.73 | 2.99 | 4.33 | 3.2 |
ROE(%) | 5 | 9.63 | 13.15 | 15.96 | 13.02 |
ROCE(%) | 4.95 | 7.01 | 9.29 | 12.67 | 8.84 |
Receivable days | 15.8 | 14 | 58.23 | 65.35 | 43.94 |
Inventory Days | 424.29 | 164.55 | 180.7 | 230.79 | 354.85 |
Payable days | 513.94 | 138.61 | 165.89 | 204.53 | 276.54 |
PER(x) | 0 | 0 | 0 | 9.99 | 12.19 |
Price/Book(x) | 0 | 0 | 0 | 1.22 | 1.48 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 2.51 | 0.88 | 0.75 | 0.97 | 1.38 |
EV/Core EBITDA(x) | 12.58 | 9.67 | 6.59 | 8.28 | 13.2 |
Net Sales Growth(%) | 0 | 205.16 | 2.87 | 39.1 | 22.67 |
EBIT Growth(%) | 0 | 52.6 | 40.23 | 54.63 | 8.66 |
PAT Growth(%) | 0 | 189.72 | 95.25 | 86.75 | 14.96 |
EPS Growth(%) | 0 | 44.86 | 95.25 | 49.59 | 14.96 |
Debt/Equity(x) | 4.51 | 2.16 | 1.7 | 0.86 | 1.82 |
Current Ratio(x) | 1.43 | 1.73 | 1.58 | 1.52 | 1.61 |
Quick Ratio(x) | 0.27 | 0.49 | 0.72 | 0.29 | 0.23 |
Interest Cover(x) | 1.7 | 2.2 | 2.71 | 4.25 | 3.53 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.66 | 1.15 |
# | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|
Promoter | 71.69 | 71.69 | 71.69 | 71.69 | 71.69 |
FII | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 |
Public | 28.31 | 28.31 | 28.31 | 28.31 | 28.31 |
Others | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 |
# | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|
Promoter | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 |
FII | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 |
Public | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
Others | 0 | 0 | 0 | 0 | 0 |
Total | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About